ASX - By Stock
|
DLI |
Re:
Ann: Mt Ida Maiden Lithium Resource 12.7Mt at 1.2% Li2O
|
|
Fyfee
|
99 |
36K |
2 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
99
|
36K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
3 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
21K
|
7.3M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
3 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
21K
|
7.3M
|
3
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Phenomenal Results From Mount Hope - 60m @ 3.1% Copper
|
|
Fyfee
|
279 |
138K |
9 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
279
|
138K
|
9
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Phenomenal Results From Mount Hope - 60m @ 3.1% Copper
|
|
Fyfee
|
279 |
138K |
27 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
279
|
138K
|
27
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Phenomenal Results From Mount Hope - 60m @ 3.1% Copper
|
|
Fyfee
|
279 |
138K |
18 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
279
|
138K
|
18
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Greater Duchess Update - 75m Copper Sulphide Vein at Mt Hope
|
|
Fyfee
|
204 |
89K |
1 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
204
|
89K
|
1
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Greater Duchess Update - Booming IP Anomaly at Mount Hope
|
|
Fyfee
|
330 |
140K |
3 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
330
|
140K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
Ann: High Grades Continue at Greater Duchess
|
|
Fyfee
|
89 |
47K |
10 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
89
|
47K
|
10
|
|
ASX - By Stock
|
CNB |
Re:
Ann: High Grades Continue at Greater Duchess
|
|
Fyfee
|
89 |
47K |
2 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
89
|
47K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
Ann: High Grades Continue at Greater Duchess
|
|
Fyfee
|
89 |
47K |
1 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
89
|
47K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Fyfee
|
438 |
177K |
32 |
03/07/22 |
03/07/22 |
ASX - By Stock
|
438
|
177K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma
|
|
Fyfee
|
91 |
33K |
8 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
91
|
33K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene data published in Cancer Research Journal
|
|
Fyfee
|
38 |
14K |
27 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
38
|
14K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene data published in Cancer Research Journal
|
|
Fyfee
|
38 |
14K |
15 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
38
|
14K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene AML trial in Israel advances to Phase 2
|
|
Fyfee
|
233 |
82K |
41 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
233
|
82K
|
41
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Stunning Drill Results 68m @ 2.4% Copper at Greater Duchess
|
|
Fyfee
|
209 |
101K |
17 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
209
|
101K
|
17
|
|
ASX - By Stock
|
CAI |
Re:
Bluespec expansion
|
|
Fyfee
|
3 |
1.9K |
2 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
3
|
1.9K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Stunning Drill Results 68m @ 2.4% Copper at Greater Duchess
|
|
Fyfee
|
209 |
101K |
10 |
14/05/22 |
14/05/22 |
ASX - By Stock
|
209
|
101K
|
10
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Stunning Drill Results 68m @ 2.4% Copper at Greater Duchess
|
|
Fyfee
|
209 |
101K |
48 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
209
|
101K
|
48
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Stunning Drill Results 68m @ 2.4% Copper at Greater Duchess
|
|
Fyfee
|
209 |
101K |
0 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
209
|
101K
|
0
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Recommended and Unconditional Takeover Offer for Bullseye
|
|
Fyfee
|
27 |
9.8K |
1 |
15/04/22 |
15/04/22 |
ASX - By Stock
|
27
|
9.8K
|
1
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Recommended and Unconditional Takeover Offer for Bullseye
|
|
Fyfee
|
27 |
9.8K |
5 |
15/04/22 |
15/04/22 |
ASX - By Stock
|
27
|
9.8K
|
5
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Recommended and Unconditional Takeover Offer for Bullseye
|
|
Fyfee
|
27 |
9.8K |
3 |
15/04/22 |
15/04/22 |
ASX - By Stock
|
27
|
9.8K
|
3
|
|
ASX - By Stock
|
CAI |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Fyfee
|
19 |
10K |
17 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
19
|
10K
|
17
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Recommended and Unconditional Takeover Offer Extended
|
|
Fyfee
|
26 |
11K |
13 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
26
|
11K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Supply Agreement for EMD AML Trial
|
|
Fyfee
|
75 |
31K |
2 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
75
|
31K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Lady Fanny Shines and Expands On New IP Surveys and Drilling
|
|
Fyfee
|
291 |
128K |
32 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
291
|
128K
|
32
|
|
ASX - By Stock
|
CNB |
Re:
Images ND Feb - Mar
|
|
Fyfee
|
29 |
18K |
4 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
29
|
18K
|
4
|
|
ASX - By Stock
|
CNB |
Re:
Who is in the Top 20?
|
|
Fyfee
|
671 |
271K |
3 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
671
|
271K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
Who is in the Top 20?
|
|
Fyfee
|
671 |
271K |
3 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
671
|
271K
|
3
|
|
ASX - By Stock
|
EMR |
Re:
Ann: TOV: Bullseye Mining Limited 04 - Panel Receives Application
|
|
Fyfee
|
18 |
7.3K |
0 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
18
|
7.3K
|
0
|
|
ASX - By Stock
|
CNB |
Re:
Why did Directors sell shares?
|
|
Fyfee
|
59 |
19K |
1 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
59
|
19K
|
1
|
|
ASX - By Stock
|
CNB |
Re:
Why did Directors sell shares?
|
|
Fyfee
|
59 |
19K |
11 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
59
|
19K
|
11
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Lady Fanny IP Survey Lights Up Strong Chargeability Targets
|
|
Fyfee
|
228 |
78K |
32 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
228
|
78K
|
32
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Presentation - RIU Explorers Conference
|
|
Fyfee
|
31 |
12K |
31 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
31
|
12K
|
31
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Nil Desperandum Continues To Grow
|
|
Fyfee
|
521 |
172K |
1 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
521
|
172K
|
1
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Nil Desperandum Continues To Grow
|
|
Fyfee
|
521 |
172K |
13 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
521
|
172K
|
13
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Lady Fanny IP Survey Lights Up Strong Chargeability Targets
|
|
Fyfee
|
228 |
78K |
4 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
228
|
78K
|
4
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Lady Fanny IP Survey Lights Up Strong Chargeability Targets
|
|
Fyfee
|
228 |
78K |
38 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
228
|
78K
|
38
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Nil Desperandum Continues To Grow
|
|
Fyfee
|
521 |
172K |
78 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
521
|
172K
|
78
|
|
ASX - By Stock
|
NWH |
Re:
News: NWH Nrw Holdings Secured New Construction Contracts Of A$110 Million
|
|
Fyfee
|
10 |
2.3K |
3 |
12/02/22 |
12/02/22 |
ASX - By Stock
|
10
|
2.3K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Nil Desperandum Continues To Grow
|
|
Fyfee
|
521 |
172K |
41 |
12/02/22 |
12/02/22 |
ASX - By Stock
|
521
|
172K
|
41
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Nil Desperandum Continues To Grow
|
|
Fyfee
|
521 |
172K |
6 |
12/02/22 |
12/02/22 |
ASX - By Stock
|
521
|
172K
|
6
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Nil Desperandum Continues To Grow
|
|
Fyfee
|
521 |
172K |
11 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
521
|
172K
|
11
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Major Discovery Confirmed at Nil Desperandum
|
|
Fyfee
|
563 |
231K |
3 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
563
|
231K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Major Discovery Confirmed at Nil Desperandum
|
|
Fyfee
|
563 |
231K |
0 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
563
|
231K
|
0
|
|
ASX - By Stock
|
EMR |
Re:
Sprotts View
|
|
Fyfee
|
3 |
1.1K |
2 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
3
|
1.1K
|
2
|
|
ASX - By Stock
|
EMR |
Re:
Rival Chinese Bid
|
|
Fyfee
|
31 |
9.5K |
3 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
31
|
9.5K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Major Discovery Confirmed at Nil Desperandum
|
|
Fyfee
|
563 |
231K |
35 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
563
|
231K
|
35
|
|